| | Healthcare Industry | Hospitals
tPA (Tissue Plasminogen Activator) in Hospitals: Risks, Benefits & Side Effects
tPA is an IV clot-dissolving drug for heart attack, ischemic stroke, and pulmonary embolism. It converts plasminogen to plasmin, which breaks down clots.
Key Risks
- Bleeding – especially with concurrent anticoagulants.
- Stroke – paradoxical risk in high-risk patients (prior stroke/TIA).
- Allergic reaction – rash, hives, swelling, anaphylaxis.
Common Side Effects
- Nausea, vomiting, headache, flushing, dizziness, weakness
Discuss risks vs. benefits with your physician before administration.
Hospitals - Related Articles
- Industries Relying on Boiler Systems: 18 Sectors from Hospitals to Petrochemical
- 19th Century Hospitals: Conditions, Challenges, and the Dawn of Modern Medicine
- MDS Coordinator Certification: Requirements & Career Path
- Boosting Patient Rights & Understanding: Consumer Awareness in Hospitals
- Preparing for Your Hospital Stay: A Comprehensive Guide
- Clinic Disadvantages: Limited Services, Hours, and Continuity Compared to Hospitals
- Hemostats: Definition, Types, and Uses in Medical Procedures
